These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 3756669

  • 1. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.
    Carter RF, Valli VE, Lumsden JH.
    Can J Vet Res; 1986 Apr; 50(2):154-64. PubMed ID: 3756669
    [Abstract] [Full Text] [Related]

  • 2. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E, Wisman P, Moore PF, van Heerde P.
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
    Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K, Fournel-Fleury C.
    Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
    [Abstract] [Full Text] [Related]

  • 6. Gastrointestinal non-Hodgkin's lymphoma. A population-based clinicopathological study of 111 adult cases with a follow-up of 10-15 years.
    Franssila KO, Jaser N, Sivula A.
    APMIS; 1993 Aug; 101(8):631-41. PubMed ID: 8217115
    [Abstract] [Full Text] [Related]

  • 7. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping.
    Guija de Arespacochaga A, Schwendenwein I, Weissenböck H.
    J Comp Pathol; 2007 Aug; 136(2-3):186-92. PubMed ID: 17416237
    [Abstract] [Full Text] [Related]

  • 8. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
    Nizze H, Bühring U.
    Verh Dtsch Ges Pathol; 1992 Aug; 76():110-6. PubMed ID: 1283239
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E, Rutteman GR, Kuipers-Dijkshoorn NJ, van Dierendonck JH, van Heerde P, Cornelisse CJ.
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [Abstract] [Full Text] [Related]

  • 11. Management of localized non-Hodgkin's lymphoma.
    MacKenzie RG, Rusthoven JJ.
    CMAJ; 1985 Sep 15; 133(6):559-64. PubMed ID: 3896450
    [Abstract] [Full Text] [Related]

  • 12. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO.
    Vezzali E, Parodi AL, Marcato PS, Bettini G.
    Vet Comp Oncol; 2010 Mar 15; 8(1):38-49. PubMed ID: 20230580
    [Abstract] [Full Text] [Related]

  • 13. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P, Brittinger G.
    Praxis (Bern 1994); 1998 Jun 03; 87(23):793-800. PubMed ID: 9654985
    [Abstract] [Full Text] [Related]

  • 14. Non-Hodgkin's lymphomas: a simplified classification scheme.
    Krueger GR, Papadakis T, Medina JR.
    Anticancer Res; 1984 Jun 03; 4(3):103-8. PubMed ID: 6465846
    [Abstract] [Full Text] [Related]

  • 15. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, Ree HJ, Lee JD, Kim SW, Huh JR.
    Cancer; 1998 Aug 15; 83(4):806-12. PubMed ID: 9708949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A histopathologic and immunopathologic study of 209 malignant lymphoma cases from four regions of China: Suzhou, Nanjing, Qingdao and Shenyang].
    Yang K.
    Zhonghua Zhong Liu Za Zhi; 1993 Mar 15; 15(2):86-90. PubMed ID: 8223131
    [Abstract] [Full Text] [Related]

  • 18. [The characteristics of the clinical course of lymphosarcomas in conformity with the morphological variants of the WHO and Working Formulation classifications].
    Baĭdurin SA, Kaplanskaia IB, Sotnikov VM, Savchenko VG, Grigor'eva MA, Samoĭlova RS, Bychkova EN, Galil-Ogly GA, Polianskaia AM.
    Ter Arkh; 1991 Mar 15; 63(7):9-14. PubMed ID: 1788819
    [Abstract] [Full Text] [Related]

  • 19. [Non-Hodgkin's lymphomas: principles and application of the Kiel classification].
    Lennert K.
    Verh Dtsch Ges Pathol; 1992 Mar 15; 76():1-13. PubMed ID: 1283238
    [Abstract] [Full Text] [Related]

  • 20. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM, Kisseberth WC, Obradovich JE, Moore FM, London CA, MacEwen EG, Ritter MA.
    Exp Hematol; 1996 Jun 15; 24(7):807-15. PubMed ID: 8647231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.